Congress passes bipartisan FDA reform bill by December 2026

Growing bipartisan frustration with FDA inefficiencies will force legislative action. The bill will mandate stricter timelines for drug reviews and reduce bureaucratic hurdles for generics.

Implied probability (Yes)

55%